MindMaze Therapeutics Taps Neuroscience Pioneer Krakauer as U.S. Growth Advisor
Event summary
- MindMaze Therapeutics appointed Prof. John W. Krakauer as strategic advisor to support U.S. expansion on August 12, 2026.
- Krakauer is the original scientific creator of MindPod® and a leading expert in motor neuroscience and neurorehabilitation.
- The move follows a two-year RWE program showing 60% increase in therapy delivery and 17% higher community discharge rates.
- MindMaze recently established U.S. headquarters in Charlotte's Innovation District and partnered with Vibra Healthcare.
The big picture
MindMaze's appointment of Krakauer underscores its push to operationalize neuroplasticity-driven recovery solutions. The move comes as healthcare systems increasingly seek scalable platforms to address clinician shortages in neurological rehabilitation. With a growing body of real-world evidence and strategic U.S. partnerships, MindMaze is positioning itself at the forefront of neurorestorative medicine commercialization.
What we're watching
- Clinical Validation
- How MindMaze will leverage Krakauer's research to strengthen its high-dose, high-intensity paradigm in real-world settings.
- Market Penetration
- Whether the U.S. expansion can capitalize on Vibra Healthcare partnership and Charlotte headquarters to scale patient access.
- Regulatory Dynamics
- The pace at which MindMaze advances FDA and CE-marked products through the care continuum, including home-based therapy.
Related topics
